.png)
Agenzia Italiana del Farmaco
AIFA reiterates the ban on the use of AstraZeneca’s ABV2856 batch only - AIFA reiterates the ban on the use of AstraZeneca’s ABV2856 batch only
AIFA reiterates the ban on the use of AstraZeneca’s ABV2856 batch only
The Italian Medicines Agency (AIFA) has been informed that a fake version of press release No. 632, published on 11 March 2021, is circulating on social media, indicating false batch numbers of COVID-19 AstraZeneca vaccine. For this reason, AIFA reiterates that the only batch of AstraZeneca’s vaccine subject to a ban on use in Italy is ABV2856.
AIFA wishes to remind that any action aimed at spreading fake news that is dangerous for the general public will be tackled by any means.
AIFA reserves the right to take any appropriate legal action against such unlawful disclosure.
Published on: 12 March 2021
Oggi si celebra il #WorldAutismAwarenessDay.
🔵 L'Agenzia Italiana del Farmaco sostiene la Giornata...
Vai al post →
Jelena Ivanovic, dirigente medico dell’Ufficio Procedure Europee di #HTA di #AIFA, è stata eletta Co...
Vai al post →
Biosimilari: webinar AIFA su terzo Position Paper
La Commissione Scientifica ed Economica (CSE) di ...
Vai al post →
🎙️ Il Presidente #AIFA intervistato da @presadirettarai sulle false terapie a base di cellule stami...
Vai al post →
💛 28 marzo 2026 – Giornata Mondiale dell’Endometriosi 💛
#AIFA si illumina di giallo per accendere...
Vai al post →
🤝🌍 A Roma i lavori dell’EDQM Borderline Products Network Meeting
💬 Il meeting, ospitato da #AIFA...
Vai al post →
